Valuation: Compumedics Limited

Market Cap 44.95M 31.73M 27.51M 25.78M 23.51M 44.24M 3.03B 304M 119M 1.52B 119M 117M 5.06B P/E 2026 *
15x
P/E 2027 * 6.08x
Enterprise Value 44.95M 31.73M 27.51M 25.78M 23.51M 44.24M 3.03B 304M 119M 1.52B 119M 117M 5.06B EV / Sales 2026 *
0.68x
EV / Sales 2027 * 0.56x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.89%
1 week-4.26%
1 month-2.17%
3 months-19.64%
6 months-36.62%
Current year-32.84%
1 week 0.22
Extreme 0.225
0.22
1 month 0.22
Extreme 0.215
0.24
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.46
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 2010-12-15
Director of Finance/CFO 61 2009-11-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 2010-12-15
Director/Board Member 61 1999-12-31
Director/Board Member - 2022-10-26
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.26%-25.00%+36.36% 31.8M
-1.18%+2.74%+22.92%+9.58% 223B
-0.92%+1.96%-2.51%-20.17% 145B
0.00%+7.37%-16.81%+31.78% 142B
+0.53%+4.85%-49.57%+1.29% 74.52B
-0.53%+3.63%+19.16%+16.56% 53.63B
+0.03%-0.15%-16.01%-17.27% 50.14B
+0.71%+5.62%+24.11%+17.68% 41.87B
-0.63%+3.46%+39.31%+41.78% 40.89B
+2.09%+4.95%-2.04%+3.07% 32.65B
Average +0.21%+3.11%-0.65%+12.07% 80.31B
Weighted average by Cap. -0.20%+3.83%+1.80%+7.96%

Financials

2026 *2027 *
Net sales 66.3M 46.81M 40.57M 38.03M 34.68M 65.25M 4.47B 448M 175M 2.24B 176M 172M 7.46B 79.7M 56.27M 48.77M 45.72M 41.69M 78.44M 5.37B 538M 210M 2.69B 211M 207M 8.97B
Net income 3.8M 2.68M 2.33M 2.18M 1.99M 3.74M 256M 25.67M 10.02M 128M 10.07M 9.85M 428M 9M 6.35M 5.51M 5.16M 4.71M 8.86M 606M 60.79M 23.73M 304M 23.86M 23.34M 1.01B
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
26-08-12 A$0.2250 0.00% 82
26-08-10 A$0.2250 0.00% 1,486
26-08-07 A$0.2250 -4.26% 4,598
26-08-05 A$0.2350 +4.44% 27,185
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2250AUD
Average target price
0.8000AUD
Spread / Average Target
+255.56%

Annual profits - Rate of surprise